Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
desvenlafaxine, Quantity: 50 mg
Medis Pharma Pty Ltd
Desvenlafaxine
Tablet, modified release
Excipient Ingredients: hypromellose; alginic acid; citric acid monohydrate; povidone; purified talc; magnesium stearate; microcrystalline cellulose; titanium dioxide; macrogol 6000; iron oxide red
Oral
1000, 7, 14, 28
(S4) Prescription Only Medicine
For the treatment of major depressive disorder, including the preventiton of relapse. Not indicated for paediatric use.
Visual Identification: Light pink colored, diamond shaped, biconvex tablets, debossed with 'Ll89' on one side and plain on other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Registered
2014-11-26